摘要:
The present invention relates to novel N-arylamidine-substituted trifluoroethyl sulfide derivatives of the formula (I) in which X 1 , X 2 , X 3 , X 4 , R 1 , R 2 , R 3 , n are each defined as specified in the description, to the use thereof as acaricides and insecticides for control of animal pests, and to processes and intermediates for preparation thereof.
摘要:
The invention relates to the novel compounds of formula (I), wherein R, R1, R2 and R3 are defined as in claim 1. The novel compounds are inhibitors of coagulation factor Xa and are used in the prophylaxis and/or therapy of thromboembolic diseases and in the treatment of tumors.
摘要:
Novel compounds of formula (I), where X, Y, Z, R, R?1, R2 and R3¿ have the meanings given in claim 1 are inhibitors of the coagulation factor Xa and may be used for prophylaxis and/or therapy of thromboembolitic diseases and for the treatment of tumours.
摘要:
The invention concerns novel arylalkyl compounds of general formula (I) in which Q stands for O, S, SO or SO2, R1 stands for hydrogen or optionally substituted alkyl, R2 stands for hydrogen or optionally substituted alkyl, Z stands for one of the groups: (a), (b), (c), and (Y)¿n?, (X)m, R?3, R4, R5, R6, R7 and R8¿ stand for hydrogen or given substituents. The invention also concerns processes for preparing these compounds, novel intermediate products, and the use of the arylalkyl compounds as herbicides.
摘要:
The present application describes modulators of MCP-1 of formula (I) or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis, asthma, restinosis, organ transplantation, and cancer.
摘要:
A urea-urethane compound which has urea and urethane groups in the molecular structure in such amounts that the number of the urea groups (A) and that of the urethane groups (B) satisfy the following relationship: 10 (A+B) 3 wherein A and B each is an integer of 1 or larger.
摘要:
The invention relates to semicarbicides of the general formula (I), wherein R?1, R2, R3, R4¿ and I are defined as in claim 1. The compounds of formula (I) can be used as active ingredients for medicaments in human and veterinary medicine, especially for combating and preventing thromboembolic diseases such as thrombosis, myocardial infarction, arteriosclerosis, inflammations, apoplexy, angina pectoris, restenosis after angioplasty, intermittent claudication, tumors, tumor diseases and/or tumor metastases.
摘要:
A compound of formula (I) wherein: n is 1 or 2; R1 is chloro, fluoro, bromo, methyl or methoxy; R2 is as defined within; R3 is as defined within; and R4 is hydrogen or fluoro; or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof is described. The use of compounds of formula (I) in the production of an elevation of PDH activity in a warm-blooded animal such as a human being are also described. Pharmaceutical compositions, methods and processes for preparation of compounds of formula (I) are detailed.